Nephron Power: Monoclonal Gammopathy and end organ damage ( Skin, Nerves, Cornea and more):- it's not just the kidney.
Myeloma Explained | Haematology | Oncology | onthewards
Laboratory testing in the evaluation of a monoclonal protein: A practical framework for interpretation
Multiple myeloma | British Journal of Hospital Medicine
Excluding myeloma diagnosis using revised thresholds for serum free light chain ratios and M-protein levels | Haematologica
247 SPEP It Up - The Curbsiders
Cureus | Light-Chain Multiple Myeloma: A Diagnostic Challenge | Article
Serum Protein Electrophoresis | Myeloma Screen - MedSchool
UK Myeloma Forum (UKMF) and Nordic Myeloma Study Group (NMSG): guidelines for the investigation of newly detected M‐proteins and the management of monoclonal gammopathy of undetermined significance (MGUS) - Bird - 2009 -
Investigating an incidental finding of a paraprotein | The BMJ
The Newcastle upon Tyne Hospitals NHS Foundation Trust Guidelines for the Interpretation and Management of immunoglobulins and P
Paraproteins and response assessments - ppt video online download
Myeloma protein - Wikipedia
Neuromuscular Disorders Associated with Paraproteinemia | Musculoskeletal Key
Serum Protein Electrophoresis and Immunofixation Electrophoresis (SPEP/IFE) — PathElective
Cancers | Free Full-Text | Immunoglobulin M Paraproteinaemias
Elevated Immunoglobulins and Paraproteins
UNDERSTANDING MULTIPLE MYELOMA AND LABORATORY VALUES
Polyclonal serum free light chain elevation is associated with increased risk of monoclonal gammopathies | Blood Cancer Journal
The use of immunoglobulin light chain assays in the diagnosis of paraprotein-related kidney disease - ScienceDirect
Frontiers | Hyperviscosity Syndrome in Paraprotein Secreting Conditions Including Waldenstrom Macroglobulinemia
247 SPEP It Up - The Curbsiders
Cancers | Free Full-Text | Monoclonal Gammopathy of Undetermined Significance (MGUS)—Not So Asymptomatic after All
Risk Stratifying Patients with Monoclonal Gammopathy of Undetermined Significance – Consult QD
Immunofixation - an overview | ScienceDirect Topics
